Fundraising Fox
Nanoflexion
1 known investors
Find your way into Nanoflexion
Sign up to see every warm intro you have to Nanoflexion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanoflexion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanoflexion is a medtech spin-off developing an electrospun nanofiber surgical patch that acts as a biodegradable, biocompatible barrier to prevent anastomotic leakage and postoperative adhesions after colorectal and gastrointestinal surgery. The patch is applied during surgery without extra tools and can serve as a local drug delivery system, targeting surgical care in Europe.
Founders & leadership
MH
Markéta Hujerová (Klíčová)FounderFounder of Nanoflexion, a medtech spin-off developing an electrospun nanofiber surgical patch designed as a biodegradable barrier to prevent anastomotic leakage and postoperative adhesions after colorectal and gastrointestinal surgery. She works at the intersection of nanotechnology and biomedicine and is engaged in science communication.
MH
Marketa Hujerova (Klicova), Ph.D.Founder & CEO
Investors · 1
Frequently asked questions
- What does Nanoflexion do?
- Nanoflexion is a medtech spin-off developing an electrospun nanofiber surgical patch that acts as a biodegradable, biocompatible barrier to prevent anastomotic leakage and postoperative adhesions after colorectal and gastrointestinal surgery. The patch is applied during surgery without extra tools and can serve as a local drug delivery system, targeting surgical care in Europe.
- Who founded Nanoflexion?
- Nanoflexion was founded by Markéta Klíčová, Markéta Hujerová (Klíčová), Marketa Hujerova (Klicova), Ph.D..
- Who are Nanoflexion's investors?
- Nanoflexion's investors include Biotech Investments S.R.O.